Decentralised and hybrid clinical trials are delivering benefits for sponsors in a number of ways – delivering quality data quicker to reduce time to market, …
Errors come in all shapes and sizes. While human errors are usually accidental, these mistakes can have far-reaching consequences in the pharmaceutical industry, including risks …
The unprecedented scale of the COVID-19 vaccination campaigns has made the world more aware of the essential role cold chain and refrigeration technologies play in …
The Covid-19 NMR Consortium, an international collaboration of NMR experts, is conducting research to determine the ribonucleic acid (RNA) structure of SARS-CoV-2 and its proteins …
Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic. Iconovo has revealed that it has received a grant of $883,800 …
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients. Roche has announced the Committee for Medicinal Products …
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A …
An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine. As of 26 …
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic. An …
The COVID-19 pandemic has brought the topic of rapid drug development to the forefront of the life sciences sector. Ray Chohan at PatSnap, believes that …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
